Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Phase 1 Completed 12 enrolled Light Sciences Oncology

NaSingle-groupOpen-labelTreatment

Summary

This is a phase 1 study to evaluate the safety and effectiveness of using the Litx™ BPH System in patients with LUTS due to benign prostatic hyperplasia (BPH).

Timeline

Start: 2008-06
Primary completion: 2011-04
Completion: 2011-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Talaporfin	Other / unclassified	1 mg/kg	Intravenous

Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Summary

Timeline

Drugs

Indications